First Cited
Last Cited

Articles citing This Document (Page 1 of 1)

Drugs and convalescent plasma therapy for COVID-19: a survey of the interventional clinical studies in Italy after 1 year of pandemicTrials2022
Drug repurposing for the treatment of COVID-19Journal of Pharmacological Sciences2022
Comparison of First and 21st Day anti SARS-CoV-2 anti-spike IgM and IgG ResponsesTurkish Journal of Immunology2022
Following the Science to Generate Well-Being: Using the Highest-Quality Experimental Evidence to Design Interventions.Frontiers in Psychology2021
Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study.Structural Chemistry2022
The Convergence of HPC, AI and Big Data in Rapid-Response to the COVID-19 PandemicCommunications in Computer and Information Science2022
Knowledge, attitude, and perception of public about participation in COVID-19 clinical trials: a study from Egypt and Saudi Arabia.Saudi Pharmaceutical Journal2022
Coronavirus Disease 2019: Clinics, Treatment, and PreventionFrontiers in Microbiology2021
“Safety and efficacy of pharmacotherapy used for the management of COVID 19: A systematic review and meta-analysis of randomized control trials”
First-described recently discovered non-toxic vegetal-derived furocoumarin preclinical efficacy against SARS-CoV-2: a promising antiviral herbal drug
COVID-19: State of the VaccinationDrugs and Therapy Perspectives2021
Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populationsJournal of Medical Biochemistry2020
COVID-19 Treatment: The Race Against TimeElectronic Journal of General Medicine2020
Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational ApproachJMIR Medical Informatics2020
Experience of creating and the first results of the prospective hospital registry of patients with suspected or confirmed coronavirus infection (COVID-19) and community-acquired pneumonia (TARGET-VIP)Profilakticheskaya Meditsina2020
Analysis of COVID-19 clinical trials: A data-driven, ontology-based, and natural language processing approachPLoS ONE2020
Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs
COVID-19 and hepatitis B infectionAntiviral Therapy2020
Does tetanus vaccination contribute to reduced severity of the COVID-19 infection?Medical Hypotheses2021
Normative framework of informed consent in clinical research in Germany, Poland, and RussiaBMC Medical Ethics2021
Research and Management of Rare Diseases in the COVID-19 Pandemic Era: Challenges and CountermeasuresFrontiers in Public Health2021
The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trialsJournal of Infection2021
Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based ReviewJournal of Inflammation Research2021
Efficacy and safety of tocilizumab in the management of COVID-19: A systematic review and meta-analysis of observational studies
Emergency Use Authorization for Remdesivir and Its Potential ImplicationsTherapeutic Innovation and Regulatory Science2021
A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)Indian Journal of Tuberculosis2021
Pregnant Women in Trials of Covid-19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical TrialsEthics & Human Research2020
Contraception and reproductive planning during the COVID-19 pandemicExpert Review of Clinical Pharmacology2020
Ten challenging questions about SARS-CoV-2 and COVID-19Expert Review of Respiratory Medicine2020
A Narrative Review of Emerging Therapeutics for COVID-19Mayo Clinic Proceedings Innovations, Quality & Outcomes2020
COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trialsBiochemical Pharmacology2020
Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access PathwaysJournal of Law, Medicine and Ethics2020
as a potential future drug molecule for COVID-19Future Drug Discovery2020
Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemicsLife Sciences2020
COVID-2019 - A comprehensive pathology insightPathology Research and Practice2020